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The validity of diagnostic definitions in psychiatry is
directly related to the extent to which their etiology
can be specified. However, since detailed knowl-
edge of causal or susceptibility factors is lacking for
most psychiatric disorders with a known or sus-
pected familial-genetic origin, the current widely
accepted classification systems largely fail to achieve
this ideal. To illustrate this problem, this paper looks
at the difficulties posed by the criteria for schizo-
phrenia as laid down in the International Classifi-
cation of Diseases, 10th revision (ICD-10) and the
Diagnostic and Statistical Manual of Mental Disor-
ders, Third Edition, Revised (DSM-III-R), and high-
lights the discrepancies between the majority of
diagnostic boundaries and the various phenotype
aggregation patterns observed in family studies.
Progress in our understanding of psychiatric disor-
ders requires to be firmly based on the findings of
epidemiological studies as well as on a clear appre-
ciation of the limitations of classification tools. 
linical diagnoses—whether in the field of psy-
chiatry or somatic medicine—seek to delineate dis-
ease entities characterized by distinct etiologies.Since
most psychiatric disorders have a familial-genetic
basis,diagnostic definitions should therefore be able to
delineate distinct familial-genetic pathways.The ideal
situation is provided when the etiological factors (ie,
the genetic mutations causing or influencing a specific
disorder) are known: in this case, the definition of the
disorder will be directly derived from the phenotype
induced by the causal or susceptibility factor(s), with
uncontroversial validity,since the definition delineates
a distinct syndrome attributable to a distinct familial-
genetic pathway.
However,to this day,such detailed knowledge of causal
or susceptibility factors remains elusive for the vast
majority of psychiatric disorders in which a familial-
genetic origin is known or suspected; in fact, the only
exception is represented by the subtypes of Alzheimer's
disease.
1 Thus, alternative strategies need to be applied
in order to formulate appropriate definitions of psychi-
atric disorders with a familial-genetic origin. But how
in this case can one judge the validity of the competing
diagnostic definitions thus derived? 
Two major criteria of validity have been proposed:
•The stronger the genetic determination,the more valid
the diagnostic definition; consequently, heritability
estimates derived from twin studies may serve as cri-
teria of validity.
•The stronger and more specific the familial aggrega-
tion,again,the more valid the diagnostic definition.
Diagnostic distinctions based
on familial-genetic studies
The two aforementioned criteria of validity were the very
ones that were used, in the past, to establish the now
widely accepted classification of affective disorders that
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191distinguishes bipolar disorder and unipolar depression:
•Twin studies established a higher degree of heritability for
bipolar disorder than for affective disorders in general.
2
• Family studies consistently demonstrated that bipolar
disorders aggregate only in families of probands with
bipolar disorder,and not in families of probands with
other subtypes of affective disorder.
3
On the basis of these findings,all currently used classifi-
cation systems,in particular the Diagnostic and Statistical
Manual of Mental Disorders (DSM) and the Interna-
tional Classification of Diseases (ICD), define the now
well-known diagnostic criteria for the two groups of
affective disorders.
More recently, an intermediate syndrome between
unipolar depression and bipolar disorder, so-called
bipolar II disorder, has been defined.This condition
is characterized by depressive episodes with manic
states too short in duration or too mild in intensity to
qualify as a manic episode.A series of family studies
(eg, Dunner et al
4) showed that bipolar II disorder
followed a specific intrafamilial pattern of aggrega-
tion. Other family studies found that bipolar II dis-
order, but not other types of bipolar disorder,
strongly aggregated in families of probands with
bipolar II disorder.
5,6 However, in contrast to the
Research Diagnostic Criteria (RDC), the currently
most widely distributed classification systems, DSM-
III-R, DSM-IV, and ICD-10, included the intermedi-
ate constellation bipolar II disorder under the head-
ing bipolar disorder.
To further illustrate the contribution of familial-genetic
studies to the classification of psychiatric disorders,this
paper takes a closer look at how the aforementioned
considerations have impacted on the diagnostic defini-
tions of schizoaffective disorders.
The first criteria-based definition of this disorder was
proposed by the RDC. This disorder was shown to
aggregate in families,but not in a specific manner.
7  Some
variants of this disorder also occurred more commonly
than would be expected by chance in families of
probands with schizophrenia and other variants in fam-
ilies of probands with affective disorders,and vice versa.
The clinical characterization of these variants demon-
strated that cosegregation with schizophrenia was pref-
erentially associated with the more chronic,schizophre-
nia-like schizoaffective disorder,whereas other subtypes
coaggregated preferentially with affective disorders.
8As
a consequence, the schizophrenia-like schizoaffective
disorders were distinguished from other schizoaffective
disorders,which were subsequently considered to belong
to the affective disorders in DSM-III-R and DSM-IV
and likewise in ICD-10.
Diagnostic definitions ignoring 
familial-genetic evidence
Several studies were recently conducted applying one of
the aforementioned criteria of validity to competing
diagnostic definitions or diagnostic criteria,particularly
with regard to the definition of schizophrenia and psy-
chotic disorders. Twin and family studies focused pri-
marily on the positive/negative distinction. It was
demonstrated that the complex of negative symptoms
was fairly consistently associated with a high familial
similarity, a higher familial loading with psychotic dis-
orders, and a higher genetic load than positive symp-
toms.
9 
One twin study even found no genetic influence at all
on the occurrence of positive symptoms (first-rank
Schneiderian symptoms), whereas other definitions,
including positive and negative symptoms in the defini-
tion of schizophrenia, were associated with at least a
moderate degree of heritability.
10 If a classification sys-
tem relies on the specificity and magnitude of underly-
ing genetic determinants,a redefinition of the concepts
of schizophrenia and other psychotic disorders should
result from these findings. In contrast to this empirical
evidence, even the most recent definitions of schizo-
phrenia and psychotic disorders in DSM-III-R, DSM-
IV, and ICD-10 give priority to positive symptoms.As
an exception,ICD-10 proposes the residual category of
latent schizophrenia (schizophrenia simplex), which is
only defined by the presence of negative symptoms, in
the absence of positive symptoms.The familial-genetic
nature of this condition is not widely known, as most
research into the genetics of schizophrenia is based on
cases with a mixture of positive and negative symptoms.
The most distinctive difference between the DSM-III-R,
DSM-IV, and ICD-10 classification of schizophrenia is
the minimal duration of the disease episodes. ICD-10
requires the presence of symptoms for just 1 month.
DSM-III-R and DSM-IV require 6 months, and con-
sider psychotic patients meeting the symptom criteria
for schizophrenia for less than 6 months to belong to
the category of schizophreniform disorders. Several
studies have shown that the course of schizophrenia
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(including episode duration) is independent of the famil-
ial loading.
11 Given this body of evidence, a differential
validity of the ICD-10 and DSM-III-R and DSM-IV def-
initions of schizophrenia is unlikely.In keeping with this
expectation,we found in a family study
12 a similar degree
of familial aggregation of schizophrenia as defined by
DSM-III-R and DSM-IV or ICD-10, although the
prevalence rates were very different (Table I).
The degree of familial aggregation is indicated by the
odds ratios (OR) with 1.0 indicating the risk in the gen-
eral population and values higher than with 1.0 indicat-
ing the degree of increased risk with respect to the gen-
eral population.A similar degree of familial aggregation
is apparent for DSM-III-R and ICD-10 in Table I,
although a difference in criteria for minimal episode
duration may result in differences in cumulative lifetime
prevalence rates.
In conclusion, although DSM-III-R and ICD-10 have
different definitions for schizophrenia,these differences
have no relevant impact on the degree of familial aggre-
gation.
Spectrum of conditions defining
the familial phenotype as
exemplified by schizophrenia
Another strategy to explore the boundaries of a famil-
ial disorder is to delineate the range of syndromes and
durations coaggregating with schizophrenia in families.
This strategy is particularly informative if relatives of
schizophrenics who are likely to have a genetic vulner-
ability to schizophrenia (so-called obligate carriers)
are investigated.Obligate carriers are relatives of schiz-
ophrenics located in the pedigree between two cases
with schizophrenia, eg, the mother of a schizophrenic
index case is considered to be an obligate carrier if one
of her siblings or one of her parents was also suffering
from schizophrenia or another psychotic disorder
(independently of the phenotype of the mother of the
index case).As the familial aggregation of schizophre-
nia is unlikely to be due to random variation (because
of the low prevalence rate in the general population),
or nongenetic familial factors (as evidenced by twin
studies), the only remaining possibility is genetic fac-
tors.Thus,differences in the prevalence of obligate car-
riers of disorders, syndromes, and behavioral devia-
tions in families of schizophrenics are likely to be
expressed by the genetic diathesis of schizophrenia.
Table II shows the cumulative lifetime prevalences of
psychiatric disorders (DSM-III-R) for obligate carriers
identified in our aforementioned family study.
12 The
excess of diagnosis-specific prevalence rates is only sig-
nificant for two groups of disorders (due to sample size
limitation). It is apparent that the genetic vulnerability
to schizophrenia is not only expressed as schizophrenia.
These findings are in keeping with those of another
series of family studies,which showed that all variants of
nonaffective psychotic disorders (schizotypal personality
disorders and schizoaffective disorders) cosegregated
with schizophrenia.
13 
Similarly, some family studies reported an excess of
affective disorders (particularly psychotic affective dis-
orders) in subjects at elevated risk for schizophrenia.In
addition,one series of family studies
12 demonstrated that
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Diagnosis of schizophrenia in  Lifetime prevalence rates Relative risk (OR) 
relatives of schizophrenics [95% confidence interval]
Relatives of probands with  Relatives of general 
schizophrenia  population probands (n = 500)
(ICD-10: n=620,DSM-III-R: n=485) 
by ICD-10 6.5% 0.9% 7.1
[3.5; 11.9]
by DSM-III-R 3.0% 0.5% 6.0
[2.0; 12.0]
Table I. Cumulative lifetime prevalence rates for schizophrenia: first-degree relatives of probands with schizophrenia by two diag-
nostic systems. Abbreviations: DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition; ICD-
10, International Classification of Diseases, 10th Revision; OR, odds ratio.a heterogeneous collection of deviations (eg,personality
deviations not qualifying as a disorder,neuropsycholog-
ical deficits) might also develop as a consequence of an
increased risk for schizophrenia.Thus, the range of the
phenotype transmitted in families of schizophrenics is
not at all identical to the diagnostic boundaries pro-
posed by any diagnostic manual.
On the other hand, there is also evidence that spe-
cific subtypes of schizophrenia aggregate in families
with a very specific pattern of aggregation. Recently,
Beckmann et al
14 demonstrated that periodic catato-
nia defined a homogeneous familial aggregation pat-
tern. However, this specific psychotic syndrome is
only remotely associated with the catatonic subtype of
schizophrenia defined by ICD-10 and DSM-III-R.
Taken together, the diagnostic distinctions and bound-
aries defined by ICD-10 and DSM-III-R are not com-
patible with the phenotype of schizophrenia trans-
mitted in families, although these diagnostic
categories were shown to be familial and under
genetic control.
Diagnostic definitions and linkage studies
Consequently, it is not surprising that linkage studies
tracing the localization of susceptibility genes for a
specific psychiatric disorder have failed to reveal a
specific relationship to diagnostic categories. Two
examples of this are discussed in the following.
• One replicated linkage finding in schizophrenia is
on 6p.
15 Maximal logarithm of the odds of linkage
(LOD) scores indicate the strength of cosegrega-
tion of genetic markers and the disease. Compari-
son of the maximal LOD scores across diagnostic
definitions (by DSM-III-R), varying by restric-
tiveness, revealed maximal diagnosis-specific LOD
scores for the broadest definition including all
variants of psychotic disorders; the maximal LOD
score for narrowly defined schizophrenia was sub-
stantially lower.
• Several candidate regions in the genome are likely
to host susceptibility genes for bipolar affective
disorders. One of these regions is 18p.A suggested
linkage to bipolar disorder was found by several
independent linkage studies in bipolar disorder.
Recently, Schwab et al
16 also found suggested link-
age for schizophrenia to the same pericentromeric
candidate region. In addition, the diagnosis-spe-
cific maximal LOD score was substantially
increased by including not only schizophrenia and
schizoaffective disorders in the phenotype, but also
affective disorders.
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Obligate carriers Matched controls
(n=41) (n=41)
Schizophrenia/ 8.2% 0.9%*
schizophreniform disorders
Schizoaffective disorders 1.2% 0%
Other nonaffective psychoses 
(including schizotypal  2.3% 1.1%
personality disorders) 
Psychotic affective disorders 3.0% 1.0%
Nonpsychotic affective  18.0% 9.1%*
disorders
Other psychiatric disorders 20.9% 18.4%
Table II. Lifetime prevalences in relatives of schizophrenics (obligate carriers) and controls. *P≤ 0.05. 
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Clasificación diagnóstica e investigación
familiar y genética en los trastornos
psiquiátricos
La validez de las definiciones diagnósticas en psiquia-
tría se relaciona directamente con la posibilidad de
especificar su etiología. Ya que se carece de un
conocimiento detallado de la etiología o de los factores
de susceptibilidad de gran parte de los trastornos
psiquiátricos con un origen familiar-genético, cono-
cido o sospechado,los sistemas clasificatorios actuales
no permiten conseguir este objetivo.Con el fin de ilus-
trar este problema, el presente artículo examina las
dificultades planteadas por los criterios de esquizofre-
nia establecidos en la Clasificación Internacional de
Enfermedades en su décima versión (CIE-10) y en el
Diagnostic and Statistical Manual of Mental Disor-
ders, en su tercera edición revisada (DSM-III-R). Se
destacan las discrepancias entre la mayoría de los
límites diagnósticos y los diversos modelos de agre-
gación fenotípica observados en estudios familiares.
El progreso en la comprensión de los trastornos
psiquiátricos requierede una base firme en los hallaz-
gos de los estudios epidemiológicos como también en
una apreciación clara de las limitaciones de los instru-
mentos clasificatorios.
Classification diagnostique et recherche
sur l'étiologie familiale/génétique des
maladies psychiatriques
La validité des définitions diagnostiques en psychia-
trie est directement liée à la possibilité de spécifier l'é-
tiologie des maladies concernées. Or, à partir du
moment où pour la plupart des maladies psychia-
triques,avec une origine génétique connue ou suspec-
tée, on ne connaît que peu les facteurs causaux ou
prédisposants, les classifications actuelles, largement
acceptées, ne permettent généralement pas de remplir
cet objectif. Cet article illustre ce problème à travers
les difficultés rencontrées avec les critères de la schizo-
phrénie de l’International Classification of Diseases,
10e révision,du Diagnostic and Statistical Manual of
Mental Disorders, 3e édition révisée (DSM-III-R).
L’auteur souligne à quel point le fossé est grand entre
la plupart des entités diagnostiques et les divers mod-
èles phénotypiques observés dans les études famil-
iales.Si notre progression dans la compréhension des
troubles psychiatriques doit se fonder sur les résultats
des études épidémiologiques, il faut garder à l’esprit
les limites des outils de classification qui sont à notre
disposition.
Conclusion
These two examples highlight the limited value of the
currently most widely accepted diagnostic definitions
of psychotic disorders for the identification of spe-
cific genetic vulnerabilities. However, there is cur-
rently no other option to the diagnosis-based linkage
and association approach to localize disease genes.
The limited validity of diagnostic definitions and their
putative loose relationship to specific genetic vulner-
abilities have to be compensated for by extension of
sample size. Once the first susceptibility genes have
been detected, more specific genotype–phenotype
relationships can be identified. ❏
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